23+ hour, 41+ min ago  (93+ words) A Single, Integrated Workflow Across Three Category Leaders Ginkgo Datapoints: Data Generation. All five Tier 1 assays (microsomal stability, cell permeability, kinetic solubility, CYP inhibition, and plasma protein binding) are executed end-to-end in Ginkgo's automated laboratory in Boston. Validated, standardized workflows…...

1+ day, 14+ hour ago  (291+ words) HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 (GLOBE NEWSWIRE) -- AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co. , Ltd. , a leader in transdermal drug delivery, to provide microbial contract development and manufacturing services for KTP-001, a recombinant human…...

1+ hour, 29+ min ago  (160+ words) Utilizing a novel dual-strike mechanism, the proprietary combination agent has the potential to deliver a low pill burden option to manage existing and future outbreaks Interactions planned with the US Centers for Disease Control and Prevention (CDC), and ongoing with the…...

28+ min ago  (499+ words) NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINews Wire - Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINews Wire ('AINW'), one of 75+ brands within the Dynamic Brand Portfolio@IBN (Investor Brand Network), a specialized communications…...

6+ day, 4+ hour ago  (197+ words) " "Of first 20 patients, all four MRD-negative patients have converted to complete response (CR)" " " "CR rate now 95% (19 of 20 patients)" " " All CRs reached within 1 year of follow-up post-dosing" " " No relapses to-date observed for patients who have reached CR" " " All subsequently enrolled patients…...

3+ hour, 44+ min ago  (317+ words) TOKYO, May 27, 2026--Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute. .. Oops, something went wrong Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi…...

1+ day, 11+ hour ago  (267+ words) Regeneron Pharmaceuticals has announced plans to establish its Global Capability Centre (GCC) in Hyderabad, India, set to be operational by the latter half of 2026. The new GCC will heavily bolster Regeneron's operations through advancements in areas like data management, artificial…...

5+ hour, 41+ min ago  (301+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...

1+ hour, 14+ min ago  (657+ words) Conexeu Sciences just 3 D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction " and the wider field of tissue regeneration " evolves, the next 18 months matter. Conexeu Sciences…...

3+ hour, 45+ min ago  (636+ words) Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis APEX Part B met all primary and secondary endpoints with high statistical significance; mid-dose zumilokibart planned to advance into…...